In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1490 News Items found
Dr. Fumiko Chino
The Cost of Cancer Treatment: Financial Toxicity and How To Manage It

Dr. Diane Reidy-Lagunes gets answers and advice from two experts in financial toxicity in cancer treatment: Dr. Fumiko Chino, radiation oncologist at MSK and inaugural winner of the ASCO Excellence in Equity Award; and Dr. Emeline Aviki, gynecologic surgeon and head of the Affordability Working Group at MSK.
MSK medical oncologist Behfar Ehdaie, who specializes in treating prostate cancer.
High-Intensity Focused Ultrasound (HIFU) Can Control Prostate Cancer With Fewer Side Effects

Learn how high-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation.
(From left) Bharat and his partner, Gregory, at Valley of Fire State Park in Nevada
Celebrating Pride: Somewhere Over the Rainbow

Pride Month 2022 is in full effect in the U.S. Many of us are seeing messages of allyship as we scroll on social media or stroll along our communities’ Main Street.
MSK molecular geneticist Elli Papaemmanuil
Improved Scoring System for Myelodysplastic Syndromes Could Help Doctors Tailor Treatment

The revised scoring system incorporates molecular information related to 31 genes to help predict risk.
Side-by-side headshots of scientists Christopher Lima and Rhyan Puno
With Cryo-EM, SKI Scientists Determine Structure of Key Factor in RNA Quality Control

Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.
Lucy Fleming
Celebrating Pride: Lucy Fleming Shares Positive Energy in MSK’s Patient Access Service

Within moments of speaking with Lucy Fleming, you notice she is always smiling. It’s a bright smile that radiates warmth. Lucy channels this positive energy as manager of the Patient Access Service at Memorial Sloan Kettering Cancer Center (MSK).
MSK radiation oncologist Jonathan Yang, who specializes in treating metastatic cancer.
Proton Therapy for Leptomeningeal Metastasis Could Be a Major Advance

Learn how proton therapy can be an effective new treatment for leptomeningeal metastasis.
Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators.
Rectal Cancer Disappears After Experimental Use of Immunotherapy

Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.
In the Clinic
Shanu Modi
Trastuzumab Deruxtecan (T-DXd) for Treating HER2-Low Breast Cancer Shows Promise

At the annual ASCO meeting, MSK medical oncologist Shanu Modi is presenting results from a clinical trial that found more people can benefit from a targeted therapy for breast cancer than previously thought.
MSK physician-scientist Vinod Balachandran.
MSK mRNA Pancreatic Cancer Vaccine Trial Shows Promising Results

Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.